In a human glioma model, inhibition of IRE1α led to downregulation of pro-angiogenic factors, and in a mouse model, reduced IRE1α expression resulted in diminished tumor growth(Auf et al. 2010). This evidence concerns the gene ERN1 and neoplasm.